Farmington, CTNCT06731764Now EnrollingIRB Ready

Hypothyroidism Clinical Trial in Farmington, CT

Access cutting-edge hypothyroidism treatment through this clinical trial at a research site in Farmington. Study-provided care at no cost to qualified participants.

Sponsored by UConn Health

Quick Self-Assessment

See if you qualify for this Farmington location

Preparing your pre-screening questions…

Expert Care in Farmington

Access hypothyroidism specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hypothyroidism treatment provided free

Apply for This Farmington Location

Check if you qualify for this hypothyroidism clinical trial in Farmington, CT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Farmington

    Convenient for CT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Farmington site if eligible
  4. 4Begin participation

About This Hypothyroidism Study in Farmington

Hypothyroidism is a common condition, more frequent in females, associated with excess of cardiovascular risk and poor quality of life not completely abrogated by treatment with levothyroxine. There is an unmet need to define a safe, effective, and feasible regimen to be applied in large trials aimed at assessing levothyroxine/liothyronine combination therapy in patients living with hypothyroidism. To address this knowledge gap we propose a randomized, three-arm, double-blind, controlled, escalating dose parallel pilot study whose results will lay the foundation of large multicenter trial(s) able to demonstrate the effectiveness (or lack thereof) of levothyroxine/liothyronine combination therapy.

Sponsor: UConn Health

Who Can Participate

Inclusion Criteria

History of hypothyroidism Treatment with levothyroxine Levothyroxine dose \>1.2 mcg/kg

Exclusion Criteria

Body weight \<50 or \>100 Kg. Indication for TSH suppression (high risk follicular-derived thyroid cancer). Secondary (pituitary) hypothyroidism (ICD-10 E23.0); Pregnancy; breastfeeding; uncontrolled diabetes (HbA1c \>8.5% at screening); use of oral Semaglutide (Rybelsus); Uncontrolled Hypertension (BP \> 140/90 at screening); current use of T3-containing therapies (Liothyronine, desiccated thyroid extracts). Patients receiving lipid-lowering therapies must maintain the same dose throughout the participation in the study. Changes in lipid lowering therapy/dose will result in termination from the study. Patients receiving anti-acid (H2 blockers, proton pump inhibitors) therapies must maintain the same dose throughout the participation in the study. Changes in anti-acid therapy/dose will result in termination from the study. Use of other medications known to interfere with the absorption of thyroid hormone, or affecting the thyroid hormone axis (Burch 2019) will be considered exclusion criteria. Bariatric surgery, initiation of GLP-1 agonist therapy (irrespective of the indication), enrollment in structured weight loss programs will result in dismissal from the study. Current pregnancy, pregnancy planned within the next 6 months, and lack of contraception in women of reproductive age will be exclusionary. We will verify that the participant is not pregnant through a urine pregnancy test at the time of the first study visit and at each of the follow-up visits. Any participants who become pregnant will terminate the study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Farmington?

Yes, this clinical trial (NCT06731764) has an active research site in Farmington, CT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hypothyroidism Treatment Options in Farmington, CT

If you're searching for hypothyroidism treatment options in Farmington, CT, this clinical trial (NCT06731764) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Farmington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hypothyroidism specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hypothyroidism clinical trials near you to find additional studies recruiting in your area.

More Thyroid Disease Trials in Farmington, CT

See all thyroid disease clinical trials recruiting in Farmington — not just this study.

Browse Thyroid Disease Trials in Farmington →

Browse More Trials by Condition

Thyroid Disease TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Farmington?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Farmington, CT